Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Perspective Therapeutics (CATX) Return on Sales (2016 - 2023)

Perspective Therapeutics' Return on Sales history spans 14 years, with the latest figure at 0.01% for Q4 2023.

  • On a quarterly basis, Return on Sales changed N/A to 0.01% in Q4 2023 year-over-year; TTM through Dec 2023 was 0.15%, a N/A change, with the full-year FY2023 number at 0.06%, changed N/A from a year prior.
  • Return on Sales hit 0.01% in Q4 2023 for Perspective Therapeutics, up from 0.0% in the prior quarter.
  • Over the last five years, Return on Sales for CATX hit a ceiling of 0.01% in Q4 2023 and a floor of 0.02% in Q3 2022.
  • Historically, Return on Sales has averaged 0.0% across 5 years, with a median of 0.0% in 2022.
  • Biggest five-year swings in Return on Sales: decreased -1bps in 2021 and later rose 2bps in 2023.
  • Tracing CATX's Return on Sales over 5 years: stood at 0.0% in 2019, then grew by 10bps to 0.0% in 2020, then plummeted by -55bps to 0.01% in 2021, then tumbled by -316bps to 0.02% in 2022, then skyrocketed by 145bps to 0.01% in 2023.
  • Business Quant data shows Return on Sales for CATX at 0.01% in Q4 2023, 0.0% in Q3 2023, and 0.01% in Q2 2023.